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uncommon manifestation of Lyme borreliosis, physicians 
need to be aware of this diagnosis, in particular in countries 
where the incidence of Lyme borreliosis has increased dur-
ing the past decades.
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Introduction
Lyme borreliosis is an infectious disease caused by Borrelia 
burgdorferi sensu lato species, and transmitted through tick 
bites. In Europe, the main vector of Lyme borreliosis is Ixo-
des ricinus, and at least five Borrelia burgdorferi sensu lato 
species can cause Lyme borreliosis: B. afzelii and B. garinii, 
and to a lesser degree also B. burgdorferi sensu stricto, B. 
bavariensis and B. spielmanii. Erythema migrans is the most 
common early manifestation of Lyme borreliosis, while 
disseminated infection can develop two to three months 
after initial infection, manifesting in the nervous system, 
joints, skin and sometimes the heart [1]. Symptomatic car-
diac involvement associated with Lyme borreliosis usually 
occurs simultaneously with or shortly after other disease 
manifestations of Lyme borreliosis. Lyme carditis typically 
manifests as conduction abnormalities with varying degrees 
of atrioventricular conduction defects (AV block), although 
other cardiac manifestations such as endomyocarditis and 
pericarditis have also been reported [1, 2]. Although usually 
self-limiting, these cardiac conduction abnormalities can 
occasionally be life-threatening, as illustrated by a recent 
publication on three sudden death cardiac events associated 
with Lyme carditis in the United States [3]. The diagnosis 
of Lyme carditis is usually based on acute onset of relevant 
symptomatic cardiac disorders, with electrocardiogram 
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(ECG) abnormalities and positive serology for Borrelia 
antibodies, and can be supported by a history of Lyme bor-
reliosis or tick bite. Alternative explanations for the cardiac 
condition need to be excluded [1, 2].
Nationwide cross-sectional retrospective surveys among 
all general practitioners (GPs) in the Netherlands have 
shown a persistent increase in the incidence of GP consulta-
tions for tick bites and erythema migrans between 1994 and 
2009, with up to 93,000 cases with tick bites and 22,000 
cases with erythema migrans seen by all GPs in the Nether-
lands in 2009 [4]. Neighbouring countries have also reported 
an increasing incidence of Lyme borreliosis [5]. To estimate 
the incidence of Lyme carditis in the Netherlands in 2009 
and 2010, we surveyed all GPs in the Netherlands, as part 
of a broader survey on physician-reported incidence of all 
Lyme borreliosis manifestations [6]. To verify and adjust 
the crude (GP reported) incidence rate of Lyme carditis from 
this nationwide cross-sectional retrospective incidence sur-
vey, we reviewed the medical records of Lyme carditis cases 
reported by GPs.
Methods
To rapidly assess a nationwide representative incidence 
rate for Lyme carditis, we performed a two-step approach. 
Firstly, a broad inquiry was required to detect a very uncom-
mon disease manifestation such as Lyme carditis. We sent 
a two-page retrospective questionnaire about Lyme borreli-
osis diagnoses during the two-year period of 2009–2010, 
also including diagnoses of Lyme carditis, to all (n = 9178) 
GPs in the Netherlands. In the Netherlands, Lyme carditis is 
usually diagnosed and treated by medical specialists in the 
hospital, and not by GPs. However, in general, patients are 
required to consult a GP to be referred to a hospital, except 
in urgent situations, and medical specialists report back to 
the GP. As every person in the Netherlands is registered with 
only one GP, the practice populations of reporting GPs were 
used to calculate crude annual incidence rates and national 
estimates of annual total numbers among the 16.6 million 
population of the Netherlands in 2010. The accompanying 
clinical case definition with regard to Lyme carditis was: 
‘Acute onset of atrioventricular (I–III) conduction defects, 
rhythm disturbances, sometimes myocarditis or pancarditis. 
Alternative explanations must be excluded’, as proposed by 
Stanek et al. [1]. To achieve a high GP-response rate, we 
inquired about clinical diagnoses of Lyme carditis in the first 
step of our two-step approach, not asking the GP to look into 
laboratory diagnostics that had been ordered and interpreted 
by medical specialists in the hospital. Instead, the labora-
tory diagnostics were verified in the second part of our 
two-step approach: systematic review of medical records of 
the GP-reported Lyme carditis patients, to verify this crude 
incidence rate of Lyme carditis, obtained from our larger 
incidence survey on all manifestations of Lyme borreliosis 
[6]. We asked cooperation of all GPs who reported Lyme 
carditis diagnoses in the questionnaire. All relevant data for 
the systematic medical record review were collected by one 
medical master student (co-author CD), using a case record 
form (CRF). Assessed variables included: medical history, 
clinical symptoms (such as palpitations, dizziness, dys-
pnoea, oedema, orthopnoea, syncope, chest pain, fatigue), 
cardiac abnormalities visible on ECG, use of cardio-active 
medications, blood chemistry, Borrelia-specific tests such 
as ELISA, immunoblots, PCR and culture results, treatment 
and clinical course.
Considering the complexities in the diagnosis of Lyme 
carditis, the collected medical records were categorised 
according to the likelihood of diagnosis, into ‘very likely’, 
‘likely’, ‘possible’, and ‘not Lyme carditis’ (Table 1). In the 
absence of validated and standardised criteria, we designed 
our own criteria for this purpose, based on cardiac symp-
toms, ECG abnormalities consistent with Lyme carditis 
(any degree of atrioventricular block, or any other type of 
conduction disturbance), positive serology for Borrelia, 
anamnestic tick bites or Lyme borreliosis, clinical recovery 
after antibiotic treatment, and recovery of the ECG abnor-
mality. Based on the information available in the medical 
records, other possible causes for the cardiac symptoms 
were excluded, among which syphilis, thyroid disorders, 
familial arrhythmias, arrhythmogenic drugs, and ischaemia. 
We adjusted the crude incidence rate from this incidence 
survey according to the proportion of GP-reported Lyme 
carditis that we categorised as very likely or likely diag-
nosis. Additionally, to correct for ‘telescoping bias’ [7], 
the incidence rate was adjusted by the proportion of GP-
reported Lyme carditis cases with a clinical presentation 
within the targeted period of 2009 and 2010.
Results
The response rate to the question on Lyme carditis (Table 2) 
in the questionnaire on all Lyme borreliosis manifestations 
was 33 % (3067/9178) among GPs, whose practice popu-
lation includes about 7.7 million persons. This represents 
46 % of the 16.6 million inhabitants of the Netherlands. 
Thirty-nine cases of Lyme carditis were reported by 38 GPs. 
These 39 GP reports of Lyme carditis per 7.7 million prac-
tice population during two years account for 0.2 % of 15,624 
GP reports on all Lyme-related diagnoses (not validated) in 
our incidence survey on all manifestations of Lyme bor-
reliosis [6]. Twenty-one GPs who together reported 22 
cases answered our request for cooperation in the medical 
record review of the reported cases. Finally, eight medical 
records out of 39 GP reports could be reviewed (Table 2). 
535Neth Heart J (2015) 23:533–538
one case turned out to have been reported twice by two GPs 
working in partnership. Table 2 shows the data collection 
and classification of the eight reviewed Lyme carditis cases, 
according to likelihood of diagnosis. Table 3 provides an 
overview of the collected information from the reviewed 
medical records. Six out of eight reviewed medical records 
satisfied the criteria for a very likely diagnosis of Lyme 
carditis, one medical record was categorised as likely, and 
one was categorised as not Lyme carditis. With the infor-
mation gained in this medical record review we calculated 
an adjusted incidence rate for very likely plus likely Lyme 
carditis, including the three invalid reports into the denomi-
nator of reviewed GP reports, resulting in 55 % (6/11) very 
likely diagnoses, and 9 % (1/11) likely diagnoses. Among 
the reviewed medical records, three out of eight cases 
(38 %) had a clinical presentation within the targeted period 
of 2009 and 2010. The adjusted annual incidence rate for 
very likely plus likely Lyme carditis diagnoses was 6 (95 % 
CI: 4–8) per 10 million inhabitants of the Netherlands in 
2009 and 2010. This yields an estimated total number of ten 
very likely plus likely cases diagnosed nationwide per year 
in 2009 and 2010, of which nine very likely diagnoses.
Discussion
We report the first incidence estimate of Lyme carditis in 
the Netherlands. Considering that not all patients with Lyme 
borreliosis are diagnosed correctly, we may have underesti-
mated or overestimated its true occurrence. Misdiagnosis, 
misclassification and telescoping bias were reduced through 
the systematic medical record review, showing that 64 % of 
the GP reports for Lyme carditis met our criteria for very 
likely or likely diagnosis, and 38 % had a clinical presen-
tation within the targeted period of 2009 and 2010. The 
adjusted incidence rate of six diagnoses of Lyme carditis 
per 10 million inhabitants in 2009 and 2010 may indicate 
a lower boundary of the true occurrence. Publications on 
underreporting of Lyme borreliosis suggest that the true 
incidence rate may be two to eight times higher than mea-
sured [8].
Diagnosing Lyme carditis can be very challenging, so our 
category of ‘very likely diagnosis’ still contains uncertainty. 
In the early stage of Lyme borreliosis serological assays for 
antibodies are infrequently positive, and antibody develop-
ment can be inhibited or delayed by early antibiotic treatment 
for erythema migrans. Therefore, convalescent serological 
testing, some weeks after the acute phase, is sometimes 
required [1, 2]. In our criteria for classification (Table 1), 
we considered any positive serological finding relevant to 
assess in the context of clinical presentation, treatment and 
clinical course. Although conduction abnormalities, as well 
as Borrelia-specific IgG antibodies, are common among the 
We discovered three invalid reports, as two reports were 
withdrawn after the reporting GPs declared to have marked 
a Lyme carditis case on the questionnaire erroneously, and 
Table 1 Criteria for classification of medical records according to 
likelihood of the diagnosis Lyme carditis
Very likely Acute onset of cardiac symptomsa
+ ECG abnormality consistent with Lyme 
carditisb
+ positive serologyc for Borrelia
Or: Acute onset of cardiac symptomsa
+ no ECG abnormality consistent with Lyme 
carditisb/no ECG performed
+ positive serologyc for Borrelia
+ anamnestic tick bite/anamnestic erythema 
migrans/diagnosed Lyme arthritis/
diagnosed Lyme neuroborreliosis
+ clinical recovery after antibiotic treatment
Likely Acute onset of cardiac symptomsa
+ positive serologyc for Borrelia
+ clinical recovery after antibiotic treatment
Or: ECG abnormality consistent with Lyme 
carditisb
+ positive serologyc for Borrelia
Or: Acute onset of cardiac symptomsa
+ ECG abnormality consistent with Lyme 
carditisb
+ Borrelia serology not performed
+ anamnestic tick bite/anamnestic erythema 
migrans/diagnosed Lyme arthritis/
diagnosed Lyme neuroborreliosis
+ clinical recovery after antibiotic treatment/
recovery ECG
Possible Acute onset of cardiac symptomsa
+ positive serologyc for Borrelia
+ anamnestic tick bite/anamnestic erythema 
migrans/diagnosed Lyme arthritis/
diagnosed Lyme neuroborreliosis
Or: Acute onset of cardiac symptomsa
+ positive serologyc for Borrelia
Or: Acute onset of cardiac symptomsa
+ Borrelia serology not performed





Negative serologyc for Borrelia
Other plausible causes for the cardiac symptoms were excluded, 
among which syphilis, thyroid disorders, familial arrhythmias, 
arrhythmogenic drugs, and ischaemia.
Within each classification, criteria are ordered by their importance 
for the diagnosis of Lyme carditis.
aCardiac symptoms such as palpitations, dizziness, dyspnoea, 
oedema, orthopnoea, syncope, chest pain, fatigue.
bElectrocardiogram (ECG) showing cardiac disorders consistent with 
Lyme carditis, such as any degree of atrioventricular block, or any 
other type of conduction disturbance.
cELISA and/or IgG immunoblot and/or IgM immunoblot for Borrelia 
antibodies.
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cal serology studies suggest that 0.3–4 % of patients with 
untreated Lyme borreliosis develop carditis [12−16]. So, 
Lyme carditis is diagnosed rarely relative to all manifes-
tations of Lyme borreliosis. However, several European 
countries, including the Netherlands, have reported marked 
increases in the incidence of Lyme borreliosis [4, 5]. Failure 
to properly diagnose Lyme carditis may have serious conse-
quences, with the possibility of sudden death or unnecessary 
implantation of a permanent pacemaker [3, 17]. According 
to the current study, approximately ten patients were diag-
nosed with Lyme carditis annually in the Netherlands in 
2009 and 2010. This finding emphasises that physicians 
should include Lyme carditis into the differential diagnosis, 
in particular among younger individuals with cardiac symp-
toms in the presence of conduction abnormalities without 
other apparent risk factors, especially if combined with a 
history of recent exposure to ticks [1−3, 17].
Conclusion
This study demonstrates that a nationwide representative 
incidence rate for Lyme carditis can be obtained rapidly by 
means of a two-step approach of a cross-sectional retrospec-
tive questionnaire among all GPs, followed by systematic 
review of medical records to adjust for misclassification 
general population, a coincidence of both is more likely to 
represent Lyme-related conduction abnormalities. In addi-
tion, other explanations for the cardiac condition need to be 
excluded [1, 2].
We consider the reported numbers of diagnoses and the 
medical records obtained from GPs representative of all 
cases diagnosed with Lyme carditis in the Netherlands, as 
we addressed the incidence questionnaire to all GPs nation-
wide, attaining a substantial response rate with a high cov-
erage of our countries’ population. In our larger incidence 
survey on all manifestations of Lyme borreliosis in 2010 
[6], we observed a response rate and incidence estimations 
of GP consultations for tick bites and erythema migrans that 
were similar to the preceding incidence surveys on 1994–
2009 [4]. It is possible that willingness to cooperate in the 
medical record review might be higher among GPs who are 
more confident of the diagnosis. We are unable to quantify 
this potential response bias to the medical record review, 
which could influence our outcomes toward a higher pro-
portion of likely diagnoses, and thus overestimation of the 
corrected incidence rate of Lyme carditis.
In line with our observation of 0.2 % diagnoses of Lyme 
carditis relative to all GP-reported clinical manifestations of 
Lyme borreliosis, other European physician-based studies 
report Lyme carditis in 0.3–0.7 % of cases with untreated 
Lyme borreliosis [9−11], and European epidemiologi-
Table 2 Data collection and classification of reviewed medical records, annual incidence of GP-reported Lyme carditis diagnoses per 10 million 
inhabitants and annual total numbers among the 16.6 million inhabitants of the Netherlands in 2009 and 2010
Incidence questionnaire sent to GPs N (% of 9178)
Response to question on Lyme carditis 3067 (33.4 %)
GP practice population 7,682,803
Reports of diagnosed Lyme carditis 39
Annual incidence of Lyme carditis in 2009 and 2010 per 10 million inhabitants, based on 39 GP reports of Lyme carditis per 7,682,803 
practice population
Crude incidence for Lyme carditis 25 (95 % CI: 18–34)/10,000,000
Medical record review N (% of 22)
Response on GP reported cases 22
GP unable to recall identity 7 (31.8 %)
Unwilling to cooperate 4 (18.2 %)
Invalid reports of Lyme carditis 3 (13.6 %)
Medical records reviewed 8 (36.4 %)
Classification of reviewed medical records N (% of 11)
Very likely diagnosis 6 (54.5 %)
Likely diagnosis 1 (9.1 %)
Possible diagnosis –
Not Lyme carditis 1 (9.1 %)
Invalid report of Lyme carditis, not reviewed 3 (27.3 %)
Clinical presentation within 2009 or 2010 N (% of 8)
3 (37.5 %)
Adjustedaannual incidence of Lyme carditis in 2009 and 2010 per 10 million inhabitants
Incidence for Lyme carditis 6 (95 % CI: 4–8)/10,000,000
National numbers 10
95 % CI: 95 % confidence intervals.
aAdjusted for 63.6 % very likely + likely diagnoses, and for 37.5 % clinical presentations within the targeted period of 2009 or 2010.
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Lyme borreliosis, physicians need to be aware of this diag-
nosis, in particular in countries where the incidence of Lyme 
borreliosis has increased during the past decades, as is the 
case in the Netherlands.
and telescoping bias. We report the first incidence estimate 
for Lyme carditis in the Netherlands of six Lyme carditis 
cases per 10 million inhabitants annually, in 2009 and 2010. 
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GP general practitioner, EM erythema migrans, LB Lyme borreliosis, ECG electrocardiogram, IV intravenous, q.d. once per day, b.i.d. two 
times per day, n.a. not available.
Table 3 Characteristics of eight cases with Lyme carditis, collected through medical record review
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